🇺🇸 Celecoxib 100 mg in United States

30 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 7 reports (23.33%)
  2. Arthralgia — 4 reports (13.33%)
  3. Dyspnoea — 3 reports (10%)
  4. Nausea — 3 reports (10%)
  5. Product Substitution Issue — 3 reports (10%)
  6. Anxiety — 2 reports (6.67%)
  7. Condition Aggravated — 2 reports (6.67%)
  8. Gastrointestinal Haemorrhage — 2 reports (6.67%)
  9. Infusion Related Reaction — 2 reports (6.67%)
  10. Joint Swelling — 2 reports (6.67%)

Source database →

Celecoxib 100 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Celecoxib 100 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Celecoxib 100 mg in United States?

Charles University, Czech Republic is the originator. The local marketing authorisation holder may differ — check the official source linked above.